Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
| Buyback Record Date | |
| Buyback Open Date | December 14, 2022 |
| Buyback Closing Date | March 24, 2023 |
| Issue Size (Amount) | ₹11.60 Crores |
| Buyback Price | ₹702 per Share |
Jenburkt Pharmaceuticals Ltd is coming up with BuyBack of the face value of ₹10 each, for an amount of ₹[.] Crores ('Base Issue Size') with an option to retain oversubscription up to ₹11.60 Crores.
Jenburkt Pharmaceuticals Ltd manufactures and markets pharmaceutical formulations in India and internationally across 13 countries. The company has over 850+ committed team members across functions pan-India, the company promote all the 85 brands across 100,000+ doctors regularly.
The issue opens on Dec 14, 2022 and closes for subscription on Jun 13, 2023. The shares of the company to be list at BSE.
The public issue of Jenburkt Pharmaceuticals Ltd opens on Dec 14, 2022 and closes for subscription on Jun 13, 2023.
The Jenburkt-Pharmaceuticals-Buyback are proposed to list at BSE.
This page provides Buyback news of Jenburkt Pharmaceuticals Buyback. The Jenburkt Pharmaceuticals Buyback watch offers the latest Buyback issue news and keep you updated with the latest Buyback news in India.
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
